New stroke drug shows promise in safety trial
NCT ID NCT05403866
Summary
This study tested whether a new drug called LT3001 is safe and effective for treating recent ischemic strokes. The trial involved 89 patients who received either the drug or a placebo within 24 hours of stroke symptoms starting. Researchers compared safety outcomes and how well patients recovered to see if LT3001 could help control stroke damage.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE ISCHEMIC STROKE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Chattanooga Center for Neurologic Research
Chattanooga, Tennessee, 37403, United States
Conditions
Explore the condition pages connected to this study.